CompletedPhase 2

Naltrexone in the Treatment of Trichotillomania

United States51 participantsStarted 2008-08

Plain-language summary

This is an 8-week, double-blind study of Natrexone in the treatment of trichotillomania

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. men and women age 18-75;
✓. current DSM-IV trichotillomania;
✓. hair-pulling primarily due to urges/cravings; and 4) pulling is reported as pleasurable the majority of time.

✕. unstable medical illness or clinically significant abnormalities on pre-study laboratory tests or physical examination;
✕. history of seizures;
✕. myocardial infarction within 6 months;
✕. current pregnancy or lactation, or inadequate contraception in women of childbearing potential;
✕. clinically significant suicidality;
✕. current or recent (past 3 months) DSM-IV substance abuse or dependence;
✕. illegal substance within 2 weeks of study initiation;
✕. initiation of psychotherapy or behavior therapy from a mental health professional for the treatment of trichotillomania within 3 months prior to study baseline;

National Institute of Mental Health Trichotillomania Symptom Severity Scale

Timeframe: This is the final score, measured at week 8 (final visit).

NCT IDNCT00775229

SponsorUniversity of Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-11

Results submitted2013-10-09